Scarica l'app Stockscreener
0.5264
2.71%
0.0139
Precedente Chiudi:
$0.5125
Aprire:
$0.52
Volume 24 ore:
110.68K
Relative Volume:
0.60
Capitalizzazione di mercato:
$2.23M
Reddito:
$502.40K
Utile/perdita netta:
$-7.91M
Rapporto P/E:
-0.0528
EPS:
-9.972
Flusso di cassa netto:
$-4.32M
1 W Prestazione:
+2.04%
1M Prestazione:
-45.28%
6M Prestazione:
-78.60%
1 anno Prestazione:
-90.34%
Intervallo 1D:
$0.5126
$0.5559
Intervallo di 1 settimana:
$0.4751
$0.5559
Portata 52W:
$0.45
$6.00
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Nome
60 Degrees Pharmaceuticals Inc
Settore
Industria
Telefono
202-327-5422
Indirizzo
1025 CONNECTICUT AVENUE NW, WASHINGTON
Confronta SXTP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
0.5264 | 2.17M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
60 Degrees Pharmaceuticals Inc Borsa (SXTP) Ultime notizie
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant stock benefit from AI adoptionEarnings Beat & AI Forecasted Stock Moves - ulpravda.ru
Shorts Report: Will 60 Degrees Pharmaceuticals Inc. stock benefit from AI adoption2025 Earnings Surprises & Real-Time Stock Price Movement Reports - ulpravda.ru
What risks investors should watch in 60 Degrees Pharmaceuticals Inc. stockPortfolio Return Report & Fast Entry High Yield Stock Tips - ulpravda.ru
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock maintain growth trajectoryDividend Hike & Verified Entry Point Detection - ulpravda.ru
Why 60 Degrees Pharmaceuticals Inc. Equity Warrant stock appeals to analysts2025 Valuation Update & Weekly High Potential Stock Alerts - ulpravda.ru
Movement Recap: Is 60 Degrees Pharmaceuticals Inc. stock vulnerable to regulatory risksJuly 2025 Intraday Action & Weekly Setup with ROI Potential - ulpravda.ru
Is 60 Degrees Pharmaceuticals Inc. stock a top pick in earnings seasonEarnings Recap Summary & Verified Technical Signals - ulpravda.ru
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant stock outperform Nasdaq indexMarket Activity Recap & Weekly Return Optimization Plans - ulpravda.ru
Published on: 2026-01-09 01:34:54 - ulpravda.ru
Will 60 Degrees Pharmaceuticals Inc. stock benefit from AI adoptionEarnings Overview Report & High Yield Equity Trading Tips - ulpravda.ru
Is 60 Degrees Pharmaceuticals Inc. stock a top momentum playJuly 2025 Analyst Calls & Long Hold Capital Preservation Plans - ulpravda.ru
Published on: 2026-01-08 21:47:54 - ulpravda.ru
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant stock deliver long term returnsJuly 2025 Short Interest & Safe Capital Growth Tips - ulpravda.ru
Published on: 2026-01-08 20:08:34 - ulpravda.ru
Will 60 Degrees Pharmaceuticals Inc. stock deliver consistent dividendsWeekly Trade Report & Long Hold Capital Preservation Tips - ulpravda.ru
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Progress Index
60 Degrees Pharma outlines growth strategy in investor webinar - TipRanks
60 Degrees Pharmaceuticals, Inc. Updates on Clinical Development and Regulatory Strategy - TradingView — Track All Markets
Why 60 Degrees Pharmaceuticals Inc. Equity Warrant stock appeals to dividend seekers2026 world cup usa national team final star players transition play group prediction tactical review - ulpravda.ru
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Jackson Sun
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
60 Degrees Pharmaceuticals Inc. (NASDAQ:SXTP) Sees Large Growth in Short Interest - Defense World
60 Degrees Pharmaceuticals, Inc. Confirms Continuation of B-FREE Study to Assess ARAKODA® for Chronic Babesiosis Treatment - Quiver Quantitative
60 Degrees Pharmaceuticals Announces Detection of Babesia - GlobeNewswire
60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State - Sahm
Tick-borne parasite found in 1 in 4 people with chronic fatigue in new study - Stock Titan
60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Coloradoan
60 Degrees Pharmaceuticals Inc Azioni (SXTP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):